TGFB1 and Hepatic fibrosis: Knockdown of circABHD3 was performed in THLE-2 and AML12 cells (Fig 2A), which was followed by treatment with TGF-β1 to induce hepatic fibrosis to assess the impact of circABHD3 on the progression of liver fibrosis in these cell models.